Andere talen Guilin Sanjin Pharmaceutical Co., Ltd.

Aandelen

002275

CNE100000DY9

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,14 ^CNY	-0,72%		+3,98%	+4,49%

04/03	Guilin Sanjin Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
2023	Guilin Sanjin Pharma gaat land en gebouwen verkopen voor 111 miljoen yuan	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Guilin Sanjin Pharma to Sell Land, Buildings For 111 Million Yuan	28/12
Guilin Sanjin Pharmaceutical Co., Ltd. Implements Profit Distribution plan for the Third Quarter of 2023, Payable on 27 November 2023	21/11
Guilin Sanjin Pharmaceutical Co., Ltd. Approves 2023 Third Quarter Profit Distribution Plan	15/11
Guilin Sanjin Pharmaceutical Co., Ltd. Proposes Third Quarter Dividend for 2023	30-10-23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29-10-23
Guilin Sanjin Pharmaceutical Co., Ltd.(XSEC:002275) added to S&P Global BMI Index	18-09-23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Guilin Sanjin Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023	24-05-23
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	22-05-23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Board Elections	27-12-22
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Dividend for the Third Quarter of 2022	15-11-22
Guilin Sanjin Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Third Quarter of 2022	31-10-22
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28-10-22
Biocytogen Pharmaceuticals Raises $60 Million in RemeGen-Backed Hong Kong IPO	31-08-22
Biocytogen Pharmaceuticals Launches $70 Million Hong Kong IPO	19-08-22
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18-08-22
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021, Payable on 30 May 2022	24-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Guilin Sanjin Pharmaceutical Co., Ltd.

Aandelen

002275

CNE100000DY9

Andere talen

Filters